Kuhara Yuta, Ninomiya Motoki, Hirahara Satoshi, Doi Hirofumi, Kenji Shirakawa, Toyota Kazuhiro, Yano Raita, Kobayashi Hironori, Hashimoto Yasushi, Yokoyama Yujiro, Sakashita Yoshihiro, Miyamoto Katsunari
Department of Surgery, Hiroshima Memorial Hospital, 1-4-3, Honkawatyo, Nakaku, Hiroshima, Hiroshimashi Japan.
Digestive Disease Center, Hiroshima Memorial Hospital, Hiroshima, Japan.
Int Cancer Conf J. 2020 Jul 24;9(4):193-198. doi: 10.1007/s13691-020-00433-3. eCollection 2020 Oct.
The prognosis of unresectable gastric cancer remains poor. Multidisciplinary treatment of unresectable gastric cancer is, therefore, thought to be essential for improving patients' outcomes. Here, we report a successful case of multidisciplinary therapy for unresectable gastric cancer. The patient was a 69-year-old woman who was diagnosed with type 2 gastric cancer with remote lymph node metastases and peritoneal dissemination. Although shrinkage of the primary lesion and remote lymph nodes were observed following chemotherapy, we performed distal gastrectomy to deal with continuous bleeding from the primary lesion. Combination therapy with radiation and chemotherapy was effective for multiple metastases in both subclavian lymph nodes and metachronous multiple axillary lymph nodes. Nivolumab combined with radiation therapy also induced regression of remote lymph node metastases, peritoneal dissemination, and adrenal metastasis. Abscopal effects, i.e., shrinkage of the non-irradiated lesions, were also observed. Thus far, the patient has been able to maintain a good quality of life while receiving continued nivolumab therapy. Multidisciplinary therapy including immunotherapy and abscopal effect may improve the quality of life and contribute to long-term survival of patients with unresectable gastric cancer.
不可切除胃癌的预后仍然很差。因此,不可切除胃癌的多学科治疗被认为对改善患者预后至关重要。在此,我们报告一例不可切除胃癌多学科治疗成功的病例。该患者为一名69岁女性,被诊断为伴有远处淋巴结转移和腹膜播散的2型胃癌。尽管化疗后观察到原发灶和远处淋巴结缩小,但我们进行了远端胃切除术以处理原发灶持续出血。放疗和化疗联合治疗对锁骨下淋巴结和异时性多发腋窝淋巴结的多处转移有效。纳武单抗联合放疗也使远处淋巴结转移、腹膜播散和肾上腺转移消退。还观察到了远隔效应,即未受照射病灶的缩小。迄今为止,该患者在接受持续纳武单抗治疗的同时能够维持良好的生活质量。包括免疫治疗和远隔效应在内的多学科治疗可能会改善不可切除胃癌患者的生活质量并有助于其长期生存。